MacroGenics, Inc.
MGNX
$1.74
$0.0955.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 303.47% | 255.31% | 155.26% | 16.68% | -73.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 303.47% | 255.31% | 155.26% | 16.68% | -73.10% |
| Cost of Revenue | 3.18% | 67.74% | 9.36% | 11.76% | -7.29% |
| Gross Profit | 120.63% | 109.18% | 104.89% | 35.61% | -10,960.92% |
| SG&A Expenses | 14.48% | 25.64% | 36.13% | 4.68% | -3.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.40% | 11.71% | 14.78% | 8.94% | -4.43% |
| Operating Income | 60.35% | 45.82% | 34.28% | -0.17% | -104.22% |
| Income Before Tax | 74.08% | -136.10% | -628.88% | -295.96% | -1,930.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 73.31% | -140.17% | -639.30% | -295.96% | -1,930.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.31% | -140.17% | -639.30% | -295.96% | -1,930.74% |
| EBIT | 60.35% | 45.82% | 34.28% | -0.17% | -104.22% |
| EBITDA | 62.77% | 47.46% | 35.03% | -3.94% | -124.03% |
| EPS Basic | 73.73% | -141.03% | -637.84% | -295.19% | -1,950.55% |
| Normalized Basic EPS | 48.08% | -293.49% | -1,024.18% | -295.21% | -1,950.95% |
| EPS Diluted | 73.64% | -132.17% | -568.38% | -298.60% | -2,104.11% |
| Normalized Diluted EPS | 48.03% | -286.91% | -975.74% | -297.07% | -2,044.10% |
| Average Basic Shares Outstanding | 1.06% | 1.19% | 1.12% | 1.02% | 0.92% |
| Average Diluted Shares Outstanding | 1.01% | 0.98% | 0.90% | 0.80% | 0.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |